GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Total Liabilities

U-Neuron Biomedical (ROCO:6973) Total Liabilities : NT$29.67 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Total Liabilities?

U-Neuron Biomedical's Total Liabilities for the quarter that ended in Jun. 2024 was NT$29.67 Mil.

U-Neuron Biomedical's quarterly Total Liabilities increased from Jun. 2023 (NT$17.20 Mil) to Dec. 2023 (NT$31.20 Mil) but then declined from Dec. 2023 (NT$31.20 Mil) to Jun. 2024 (NT$29.67 Mil).

U-Neuron Biomedical's annual Total Liabilities increased from Dec. 2021 (NT$15.94 Mil) to Dec. 2022 (NT$23.04 Mil) and increased from Dec. 2022 (NT$23.04 Mil) to Dec. 2023 (NT$31.20 Mil).

U-Neuron Biomedical Total Liabilities Historical Data

The historical data trend for U-Neuron Biomedical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Total Liabilities Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Liabilities
8.54 15.94 23.04 31.20

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Liabilities Get a 7-Day Free Trial - 23.04 17.20 31.20 29.67

U-Neuron Biomedical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

U-Neuron Biomedical's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=25.665+(4.896+0.641
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=31.20

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=523.169-491.967
=31.20

U-Neuron Biomedical's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=26.514+(2.448+0.706
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=29.67

Total Liabilities=Total Assets (Q: Jun. 2024 )-Total Equity (Q: Jun. 2024 )
=490.561-460.893
=29.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical Total Liabilities Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Total Liabilities
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
https://en.u-neuron.com
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical Headlines

No Headlines